Intracellular Staphylococcus aureus in osteoblasts and osteocytes and its impact on bone homeostasis during

Quentin Collet1, Frédéric Velard2, Frédéric Laurent1

  • 1CIRI-Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Univ Lyon, Lyon, France; Laboratoire de bactériologie, Institut des Agents Infectieux, French National Reference Center for Staphylococci, Hospices Civils de Lyon, Lyon, France.

Bone
|May 20, 2025
PubMed

Insights

Osteomyelitis, a severe bone infection often caused by Staphylococcus aureus, involves bacteria invading bone cells. These infected cells promote bone loss and disrupt bone homeostasis, complicating treatment.

Area of Science:

  • Microbiology
  • Immunology
  • Orthopedics

Background:

  • Osteomyelitis is a serious bone infection with significant morbidity.
  • Staphylococcus aureus is the primary bacterial cause, leading to bone loss and osteonecrosis.
  • Bacterial internalization by bone cells is a key factor in chronic osteomyelitis.

Purpose of the Study:

  • To review literature on Staphylococcus aureus internalization by osteoblasts and osteocytes.
  • To examine the intracellular behavior and cell death mechanisms of S. aureus within bone cells.
  • To investigate S. aureus's impact on bone formation and inflammatory mediator production.

Main Methods:

  • Literature review of historical and recent studies.
  • Analysis of S. aureus internalization mechanisms in osteoblasts and osteocytes.
  • Examination of S. aureus's effects on bone cell function and mediator release.

Main Results:

  • S. aureus invades osteoblasts and osteocytes, acting as intracellular reservoirs.
  • Infected bone cells contribute to bone resorption and disrupt bone homeostasis.
  • S. aureus influences bone formation and promotes inflammatory and osteoclastogenic mediators.

Conclusions:

  • Understanding intracellular bacterial behavior is crucial for osteomyelitis pathogenesis.
  • Targeting intracellular bacteria and their effects on bone cells may offer new therapeutic strategies.
  • Further research is needed to address limitations and explore future therapeutic avenues.